325 related articles for article (PubMed ID: 26898757)
21. MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of
Liu W; Lv C; Zhang B; Zhou Q; Cao Z
RNA; 2017 Jul; 23(7):1019-1027. PubMed ID: 28396577
[TBL] [Abstract][Full Text] [Related]
22. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
[TBL] [Abstract][Full Text] [Related]
23. The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.
Huang TT; Ping YH; Wang AM; Ke CC; Fang WL; Huang KH; Lee HC; Chi CW; Yeh TS
Oncotarget; 2015 Jul; 6(20):18012-26. PubMed ID: 26041881
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
[TBL] [Abstract][Full Text] [Related]
25. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
[TBL] [Abstract][Full Text] [Related]
26. MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression.
Yan J; Jiang JY; Meng XN; Xiu YL; Zong ZH
J Exp Clin Cancer Res; 2016 Feb; 35():31. PubMed ID: 26872615
[TBL] [Abstract][Full Text] [Related]
27. MiR-23b functions as an oncogenic miRNA by downregulating Mcl-1S in lung cancer cell line A549.
Wang L; Hu Z; Guo Q; Yang L; Pang Y; Wang W
J Biochem Mol Toxicol; 2020 Jul; 34(7):e22494. PubMed ID: 32281274
[TBL] [Abstract][Full Text] [Related]
28. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
Xiang J; Bian C; Wang H; Huang S; Wu D
J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
[TBL] [Abstract][Full Text] [Related]
29. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
Chakravarthi BVSK; Chandrashekar DS; Agarwal S; Balasubramanya SAH; Pathi SS; Goswami MT; Jing X; Wang R; Mehra R; Asangani IA; Chinnaiyan AM; Manne U; Sonpavde G; Netto GJ; Gordetsky J; Varambally S
Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
31. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X
Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183
[TBL] [Abstract][Full Text] [Related]
32. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer.
Xie C; Jiang XH; Zhang JT; Sun TT; Dong JD; Sanders AJ; Diao RY; Wang Y; Fok KL; Tsang LL; Yu MK; Zhang XH; Chung YW; Ye L; Zhao MY; Guo JH; Xiao ZJ; Lan HY; Ng CF; Lau KM; Cai ZM; Jiang WG; Chan HC
Oncogene; 2013 May; 32(18):2282-91, 2291.e1-7. PubMed ID: 22797075
[TBL] [Abstract][Full Text] [Related]
33. Promising therapeutic role of miR-27b in tumor.
Ding L; Ni J; Yang F; Huang L; Deng H; Wu Y; Ding X; Tang J
Tumour Biol; 2017 Mar; 39(3):1010428317691657. PubMed ID: 28351320
[TBL] [Abstract][Full Text] [Related]
34. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
35. MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.
Du Y; Liu XH; Zhu HC; Wang L; Ning JZ; Xiao CC
Cell Physiol Biochem; 2017; 41(3):1135-1146. PubMed ID: 28245474
[TBL] [Abstract][Full Text] [Related]
36. Novel role of the clustered miR-23b-3p and miR-27b-3p in enhanced expression of fibrosis-associated genes by targeting TGFBR3 in atrial fibroblasts.
Yang Z; Xiao Z; Guo H; Fang X; Liang J; Zhu J; Yang J; Li H; Pan R; Yuan S; Dong W; Zheng XL; Wu S; Shan Z
J Cell Mol Med; 2019 May; 23(5):3246-3256. PubMed ID: 30729664
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
38. microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.
Wei P; Qiao B; Li Q; Han X; Zhang H; Huo Q; Sun J
DNA Cell Biol; 2016 Jan; 35(1):33-43. PubMed ID: 26394192
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
Zheng H; Bai L
Exp Mol Pathol; 2019 Dec; 111():104301. PubMed ID: 31442444
[TBL] [Abstract][Full Text] [Related]
40. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
Tian X; Tao F; Zhang B; Dong JT; Zhang Z
IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
